XML 52 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Intangible Assets
12 Months Ended
Dec. 31, 2021
Disclosure of detailed information about intangible assets [abstract]  
Intangible Assets

16. Intangible assets

 

Balances and changes in intangible assets are as follows: 

 

 

Weighted average useful life (years)

Balance on 12/31/2020


 

Additions


 

Amortization


 

Transfer (i)


 

Write-offs and disposals


 

Effect of foreign currency exchange rate variation


 

Reclassification to assets held for sale (ii)


 

Balance on 12/31/2021


Cost:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


Goodwill (a)

 

1,525,088

 

-


 

-


 

-


 

-


 

-


 

(706,992

)

 

818,096


Software (b)

4

1,395,046


 

284,311


 

-


 

372


 

(19,826

)

 

1,808


 

(514,731

)

 

1,146,980


Technology (c)

 

32,617


 

-


 

-


 

-


 

-


 

-


 

(32,617

)

 

-


Distribution rights

12

133,599


 

-


 

-


 

-


 

-


 

-


 

(19,006

)

 

114,593


Brands (d)

 

136,962


 

-


 

-


 

-


 

-


 

4,759


 

(72,523

)

 

69,198


Trademark rights (d)

39

114,792


 

-


 

-


 

-


 

-


 

-


 

-


 

114,792


Others (e)

10

50,698


 

1,678


 

-


 

-


 

-


 

(76

)

 

(51,879

)

 

421


Decarbonization credits (f)

 

-


 

176,837


 

-


 

-


 

(176,837

)

 

-


 

-


 

-


 

 

3,388,802


 

462,826


 

-


 

372


 

(196,663

)

 

6,491


 

(1,397,748

)

 

2,264,080


Accumulated amortization:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


Software

 

(825,024

)

 

-


 

(206,025

)

 

(203

)

 

19,329


 

(1,566

)

 

334,087


 

(679,402

)

Technology

 

(32,616

)

 

-


 

-


 

-


 

-


 

-


 

32,616


 

-


Distribution rights

 

(113,326

)

 

-


 

(3,093

)

 

-


 

-


 

-


 

15,392


 

(101,027

)

Trademark rights

 

(9,056

)

 

-


 

(2,937

)

 

-


 

-


 

-


 

-


 

(11,993

)

Others

 

(32,845

)

 

-


 

(167

)

 

-


 

-


 

(2

)

 

32,612


 

(402

)

 

 

(1,012,867

)

 

-


 

(212,222

)

 

(203

)

 

19,329


 

(1,568

)

 

414,707


 

(792,824

)

Provision for losses and impairment:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


Goodwill (a)

 

(593,280

)

 

(68,273

)

 

-


 

-


 

-


 

-


 

661,553


 

-


Distribution rights

 

-


 

(76,218

)

 

-


 

-


 

-


 

-


 

76,218


 

-


 

 

(593,280

)

 

(144,491

)

 

-


 

-


 

-


 

-


 

737,771


 

-


Net amount

 

1,782,655


 

318,335


 

(212,222

)

 

169


 

(177,334

)

 

4,923


 

(245,270

)

 

1,471,256



(i) Refers to amounts transferred from PP&E.

(ii) For further information, see Note 3.c.1.


 

Weighted average useful life (years)

Balance on 12/31/2019


 

Additions


 

Amortization


 

Transfer (i)


 

Write-offs and disposals


 

Effect of foreign currency exchange rate variation


 

Balance on 12/31/2020


Cost:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


Goodwill (a)

 

1,525,088


 

-


 

-


 

-


 

-


 

-


 

1,525,088


Software (b)

4

1,210,529


 

184,027


 

-


 

993


 

(6,633

)

 

6,130


 

1,395,046


Technology (c)

 

32,617


 

-


 

-


 

-


 

-


 

-


 

32,617


Commercial property rights

 

7,934


 

-


 

-


 

-


 

(7,934

)

 

-


 

-


Distribution rights

10

133,599


 

-


 

-


 

-


 

-


 

-


 

133,599


Brands (d)

 

122,504


 

-


 

-


 

-


 

-


 

14,458


 

136,962


Trademark rights (d)

39

114,792


 

-


 

-


 

-


 

-


 

-


 

114,792


Others (e)

10

44,900


 

1,040


 

-


 

-


 

-


 

4,758


 

50,698


Decarbonization credits (f)

 

-


 

125,345


 

-


 

(1,058

)

 

(124,287

)

 

-


 

-


 

 

3,191,963


 

310,412


 

-


 

(65

)

 

(138,854

)

 

25,346


 

3,388,802


Accumulated amortization:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


Software

 

(648,861

)

 

-


 

(175,144

)

 

-


 

3,375


 

(4,394

)

 

(825,024)


Technology

 

(32,616

)

 

-


 

-


 

-


 

-


 

-


 

(32,616

)

Commercial property rights

 

(6,384

)

 

-


 

(85

)

 

-


 

6,469


 

-


 

-


Distribution rights

 

(108,932

)

 

-


 

(4,394

)

 

-


 

-


 

-


 

(113,326

)

Trademark rights

 

(6,119

)

 

-


 

(2,937

)

 

-


 

-


 

-


 

(9,056

)

Others

 

(32,713

)

 

-


 

(121

)

 

-


 

-


 

(11

)

 

(32,845

)

 

 

(835,625

)

 

-


 

(182,681

)

 

-


 

9,844


 

(4,405

)

 

(1,012,867

)

Provision for losses and impairment:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


Goodwill (a)

 

(593,280

)

 

-


 

-


 

-


 

-


 

-


 

(593,280

)

Commercial property rights

 

(465

)

 

-


 

-


 

-


 

465


 

-


 

-


 

 

(593,745

)

 

-


 

-


 

-


 

465


 

-


 

(593,280

)

Net amount

 

1,762,593


 

310,412


 

(182,681

)

 

(65

)

 

(128,545

)

 

20,941


 

1,782,655



(i) Refers to amounts transferred to property, plant and equipment and prepaid expenses.


 

Weighted average useful life (years)

Balance on 12/31/2018


 

Adoption IFRS 16


 

Additions


 

Amortization


 

Transfer (i)


 

Write-offs and disposals


 

Effect of foreign currency exchange rate variation


 

Oxiteno Andina (*)


 

Balance on 12/31/2019


Cost:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


Goodwill (a)

-

1,525,088


 

-


 

-


 

-


 

-


 

-


 

-


 

-


 

1,525,088


Software (b)

3

1,062,486


 

-


 

145,004


 

-


 

2,553


 

(784

)

 

1,551


 

(281

)

 

1,210,529


Technology (c)

5

32,617


 

-


 

-


 

-


 

-


 

-


 

-


 

-


 

32,617


Commercial property rights

10

64,032


 

(56,114

)

 

3,820


 

-


 

(1,401

)

 

(2,403

)

 

-


 

-


 

7,934


Distribution rights

6

142,989


 

-


 

1,505


 

-


 

(10,895

)

 

-


 

-


 

-


 

133,599


Brands (d)

-

120,571


 

-


 

-


 

-


 

-


 

-


 

1,933


 

-


 

122,504


Trademark rights (d)

35

114,792


 

-


 

-


 

-


 

-


 

-


 

-


 

-


 

114,792


Others (e)

10

43,281


 

-


 

1,668


 

-


 

(355

)

 

-


 

306


 

-


 

44,900


 

 

3,105,856


 

(56,114

)

 

151,997


 

-


 

(10,098

)

 

(3,187

)

 

3,790


 

(281

)

 

3,191,963


Accumulated amortization:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


Software

 

(537,438

)

 

-


 

-


 

(110,088

)

 

13


 

(611

)

 

(998

)

 

261


 

(648,861

)

Technology

 

(32,613

)

 

-


 

-


 

(3

)

 

-


 

-


 

-


 

-


 

(32,616

)

Commercial property rights

 

(23,931

)

 

16,186


 

-


 

(848

)

 

(669

)

 

2,878


 

-


 

-


 

(6,384

)

Distribution rights

 

(106,597

)

 

-


 

-


 

(6,511

)

 

4,176


 

-


 

-


 

-


 

(108,932

)

Trademark rights

 

(3,182

)

 

-


 

-


 

(2,937

)

 

-


 

-


 

-


 

-


 

(6,119

)

Others

 

(32,740

)

 

-


 

-


 

(105

)

 

136


 

-


 

(4

)

 

-


 

(32,713

)

 

 

(736,501

)

 

16,186


 

-


 

(120,492

)

 

3,656


 

2,267


 

(1,002

)

 

261


 

(835,625

)

Provision for losses and impairment:

 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


Goodwill (a)

 

-


 

-


 

(593,280

)

 

-


 

-


 

-


 

-


 

-


 

(593,280

)

Commercial property rights

 

-


 

-


 

(465

)

 

-


 

-


 

-


 

-


 

-


 

(465

)

 

 

-


 

-


 

(593,745

)

 

-


 

-


 

-


 

-


 

-


 

(593,745

)

Net amount

 

2,369,355


 

(39,928

)

 

(441,748

)

 

(120,492

)

 

(6,442

)

 

(920

)

 

2,788


 

(20

)

 

1,762,593


(i) Refers to amounts transferred to PP&E and right-of-use assets.

(*) Refers to the asset write-offs of Oxiteno Andina.

 

a. Goodwill

 

The balance of the goodwill is tested annually for impairment and is represented by the following acquisitions:

 

 

Segment

12/31/2021


 

12/31/2020


Goodwill on the acquisition of:

 

 


 

 


Extrafarma

Extrafarma

661,553


 

661,553


Extrafarma – impairment (i)

Extrafarma

(661,553

)

 

(593,280

)

Extrafarma – net

Extrafarma

-


 

68,273


Ipiranga (ii)

Ipiranga

276,724


 

276,724


União Terminais

Ultracargo

211,089


 

211,089


Texaco

Ipiranga

177,759


 

177,759


Iconic (CBLSA)

Ipiranga

69,807


 

69,807


Oxiteno Uruguay (iii)

Oxiteno

-


 

44,856


Temmar

Ultracargo

43,781


 

43,781


DNP

Ipiranga

24,736


 

24,736


Repsol

Ultragaz

13,403


 

13,403


TEAS

Ultracargo

797


 

797


Others (iii)

Oxiteno

-


 

583


 

 

818,096


 

931,808


 

(i) For further information, see Note 3.a.

(ii) Including R$ 246,163 presented as goodwill at parent Company Ultrapar.

(iii) For further information about reclassification, see Note 3.c.1.

 

On December 31, 2021, the Company tested the balances of goodwill shown in the table above for impairment. The determination of value in use involves assumptions, judgments, and estimates of cash flows, such as growth rates of revenues, costs and expenses, estimates of investments and working capital, and discount rates. The assumptions about growth projections and future cash flows are based on the Company’s business plan of its operating segments, as well as comparable market data, and represent management’s best estimate of the economic conditions that will exist over the economic life of the various CGUs, to which goodwill is related. The key-assumptions used by the Company to calculate the value in use are described below:

 

Period of evaluation: the evaluation of the value in use is calculated for a period of five years, after which the Company calculated the perpetuity, considering the possibility of carrying the business on indefinitely.

 

Discount and real growth rates: on December 31, 2021, the discount and real growth rates used to extrapolate the projections ranged from 9.4% to 10.5% and from 0% to 1% p.a., respectively, depending on the CGU analyzed.

 

Revenue from sales and services, costs and expenses, and gross margin considers the budget prepared for 2022 and the long-term strategic plan prepared by management and approved by the Board of Directors.

 

b. Software

 

Includes user licenses and costs for the implementation of the various systems used by the Company and its subsidiaries: integrated management and control, financial management, foreign trade, industrial automation, operational and storage management, accounting information, and other systems. Also include expenses related to software in progress in the amount of R$ 27,672 on December 31, 2021 (R$ 13,684 on December 31, 2020 and R$ 16,657 on December 31, 2019).

 

c. Technology

 

The subsidiaries Oxiteno S.A. and Oleoquímica recognize as technology certain rights of use held by them. Such licenses include the production of ethylene oxide, ethylene glycols, ethanolamines, glycol ethers, ethoxylates, solvents, fatty acids from vegetable oils, fatty alcohols, and specialty chemicals, which are products that are supplied to various industries. The balance was reclassified to assets of subsidiaries held for sale. For further details, see Note 3.b.

 

d. Brands and trademark rights

 

Brands are represented by the acquisition cost of the ‘am/pm’ brand in Brazil, acquired in the business combination, and Chevron and Texaco trademark rights.

 

e. Other intangibles

 

Refers mainly to the loyalty program “Clube Extrafarma” reclassified to assets of subsidiaries held for sale. For further details, see Note 3.a.

 

f. Decarbonization credits

 

Represent the CBIOS acquired and recorded at acquisition cost. The amount in the “write-offs” column refers to CBIOS retired in the year, that had its maturity date and can not be the object of future negotiation.